Biological Products, (No Diagnostic Substances)
183 listed companies the SEC classes under this industry (code 2836), in order of revenue.
166 of them have annual figures on record. The 158 reporting in US dollars had revenue of $96.6B between them in their latest fiscal years.
Each company's latest fiscal year, as its annual report to the SEC gave the figures; the year links to that report. Amounts in other currencies are not converted, and sort after those in dollars.